Summit, NJ, February 16, 2010 – Atlantic Health participates in and conducts a variety of clinical trials. One such study, International Early Lung Cancer Action Program (IELCAP) focuses on improving the rate for the early detection of lung cancer.
Lung cancer remains the top killer among men and women. Unfortunately, most lung cancer cases are detected in late stages, once the disease has progressed to a point that makes a cure difficult. Researchers in the IELCAP study are working on ways to increase the odds of early detection and better identify the at-risk population.
“Patients over age 40 with a 10-pack year history – smoking half a pack of cigarettes a day for 20 years or two packs a day for five years – and those over 40 with exposure to second-hand smoke or other carcinogens are eligible to participate,” says Mark Widmann, M.D., surgical director of the lung cancer program at the Carol G. Simon Cancer Centers at both Morristown Memorial Hospital and Overlook Hospital. “Participants can greatly impact the lives of people at risk for lung cancer.”
For more information about Overlook Hospital’s Lung Cancer Program or the IELCAP trial, call 908-522-5344.